Cell Biology International

Charcot‐Marie‐Tooth (CMT) diseases are a heterogeneous group of genetic peripheral neuropathies caused by mutations in a variety of genes, which are involved in the development and maintenance of peripheral nerves. Myelin protein zero (MPZ) is expressed by Schwann cells, and MPZ mutations can lead to primarily demyelinating polyneuropathies including CMT type 1B. Different mutations demonstrate various forms of disease pathomechanisms, which may be beneficial in understanding the disease cellular pathology. Our molecular dynamics simulation study on the possible impacts of I30T mutation on the MPZ protein structure suggested a higher hydrophobicity and thus lower stability in the membranous structures. A study was also conducted to predict native/mutant MPZ interactions. To validate the results of the simulation study, the native and mutant forms of the MPZ protein were separately expressed in a cellular model, and the protein trafficking was chased down in a time course pattern. In vitro studies provided more evidence on the instability of the MPZ protein due to the mutation. In this study, qualitative and quantitative approaches were adopted to confirm the instability of mutant MPZ in cellular membranes.

[1]  Josep Ramón Goñi,et al.  Molecular dynamics simulations: advances and applications , 2015, Advances and applications in bioinformatics and chemistry : AABC.

[2]  M. Jami,et al.  Differentiation of dental pulp stem cells into neuron-like cells , 2019, The International journal of neuroscience.

[3]  M. Jami,et al.  Increased levels of miR-124 in human dental pulp stem cells alter the expression of neural markers , 2019, Journal of otology.

[4]  M. Jami,et al.  Protein biomarkers of neural system , 2019, Journal of otology.

[5]  H. Zayed,et al.  Computational modelling approaches as a potential platform to understand the molecular genetics association between Parkinson’s and Gaucher diseases , 2018, Metabolic Brain Disease.

[6]  J. Svaren,et al.  Myelin protein zero mutations and the unfolded protein response in Charcot Marie Tooth disease type 1B , 2018, Annals of clinical and translational neurology.

[7]  M. Jami,et al.  Comparison of Three Types of Mesenchymal Stem Cells (Bone Marrow, Adipose Tissue, and Umbilical Cord-Derived) as Potential Sources for Inner Ear Regeneration. , 2017, The international tinnitus journal.

[8]  M. Jami,et al.  Molecular Mechanisms behind Free Radical Scavengers Function against Oxidative Stress , 2017, Antioxidants.

[9]  G. C,et al.  Genotype-phenotype correlation in 18 Egyptian patients with glutaric acidemia type I , 2017, Metabolic Brain Disease.

[10]  M. Jami,et al.  MicroRNAs: effective elements in ear-related diseases and hearing loss , 2017, European Archives of Oto-Rhino-Laryngology.

[11]  T. Touvier,et al.  Endoplasmic Reticulum Protein Quality Control Failure in Myelin Disorders , 2017, Front. Mol. Neurosci..

[12]  G C P van Zundert,et al.  The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes. , 2016, Journal of molecular biology.

[13]  M. Jami,et al.  Edaravone leads to proteome changes indicative of neuronal cell protection in response to oxidative stress , 2015, Neurochemistry International.

[14]  C. George Priya Doss,et al.  Impact of I30T and I30M substitution in MPZ gene associated with Dejerine-Sottas syndrome type B (DSSB): A molecular modeling and dynamics. , 2015, Journal of theoretical biology.

[15]  K. Mahnam,et al.  Improvement of Cd2+ uptake ability of SmtA protein by Lys/Cys mutation; experimental and theoretical studies , 2015, Journal of biomolecular structure & dynamics.

[16]  A. Doosti,et al.  Comparison between the cultures of human induced pluripotent stem cells (hiPSCs) on feeder-and serum-free system (Matrigel matrix), MEF and HDF feeder cell lines , 2015, Journal of Cell Communication and Signaling.

[17]  M. Babst Quality control at the plasma membrane: One mechanism does not fit all , 2014, The Journal of cell biology.

[18]  J. Lupski,et al.  The allelic spectrum of Charcot–Marie–Tooth disease in over 17,000 individuals with neuropathy , 2014, Molecular genetics & genomic medicine.

[19]  J. Polke,et al.  Clinical implications of genetic advances in Charcot–Marie–Tooth disease , 2013, Nature Reviews Neurology.

[20]  G. Braathen Genetic epidemiology of Charcot–Marie–Tooth disease , 2012, Acta neurologica Scandinavica. Supplementum.

[21]  A. Madadkar-Sobhani,et al.  Characterization of adenosine receptor in its native environment: insights from molecular dynamics simulations of palmitoylated/glycosylated, membrane-integrated human A2B adenosine receptor , 2012, Journal of Molecular Modeling.

[22]  J. Kamholz,et al.  Crystal structure of the extracellular domain of human myelin protein zero , 2011, Proteins.

[23]  G. Lukács,et al.  Protein quality control at the plasma membrane. , 2011, Current opinion in cell biology.

[24]  M. Russell,et al.  Genetic epidemiology of Charcot–Marie–Tooth in the general population , 2011, European journal of neurology.

[25]  Tal Pupko,et al.  ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acids , 2010, Nucleic Acids Res..

[26]  P. Fossa,et al.  Clinical features and molecular modelling of novel MPZ mutations in demyelinating and axonal neuropathies , 2009, European Journal of Human Genetics.

[27]  E. Carpenter,et al.  Overcoming the challenges of membrane protein crystallography , 2008, Current opinion in structural biology.

[28]  Carsten Kutzner,et al.  GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.

[29]  Alan Grossfield,et al.  Convergence of molecular dynamics simulations of membrane proteins , 2007, Proteins.

[30]  U. Suter,et al.  Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot‐Marie‐Tooth disease) , 2006, Glia.

[31]  Richard A Lewis,et al.  Phenotypic clustering in MPZ mutations. , 2004, Brain : a journal of neurology.

[32]  Berk Hess,et al.  GROMACS 3.0: a package for molecular simulation and trajectory analysis , 2001 .

[33]  Berk Hess,et al.  LINCS: A linear constraint solver for molecular simulations , 1997, J. Comput. Chem..

[34]  D. van der Spoel,et al.  GROMACS: A message-passing parallel molecular dynamics implementation , 1995 .

[35]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[36]  Haesun A Kim,et al.  Schwann Cells , 2018, Methods in Molecular Biology.

[37]  C. Verhamme Charcot-Marie-Tooth type 1A: natural course, pathophysiology and treatment , 2010 .

[38]  U. Suter,et al.  Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease , 2007, NeuroMolecular Medicine.

[39]  D. Kirschner,et al.  Inherited demyelinating peripheral neuropathies: relating myelin packing abnormalities to P0 molecular defects. , 1996, Journal of neuroscience research.